This quasi-experimental study aim to evaluate the effect of moderate aerobic exercise on glucose and lipid metabolism as well as the scales of anxiety and depression and levels of salivary cortisol in women with type 2 diabetes.
This quasi-experimental study aim to performed a 12-week training program (3 times/week, 60 minutes per session) which consisted of a supervised moderate aerobic exercise previously determined (50% to 70% of maximal Heart Rate) in women with type 2 diabetes.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
12
This is a quasi-experimental study and the same group was evaluated before and after the exercise.
Glucose levels
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glucose test.
Time frame: 3 months
Systolic and Diastolic blood pressure
Change in Systolic and Diastolic blood pressure were evaluated before and after physical exercise, during 3 months.
Time frame: 3 months
Heart Rate measurement
Change in heart rate was evaluated before, during and after physical exercise, during 3 months.
Time frame: 3 months
Glycated hemoglobin levels
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glycated hemoglobin test.
Time frame: 3 months
Proteinuria levels
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for proteinuria test.
Time frame: 3 months
Triglycerides levels
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for triglycerides test.
Time frame: 3 months
High Density Level (HDL) Cholesterol levels
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for High Density Level Cholesterol test.
Time frame: 3 months
Low Density Level (LDL) Cholesterol levels
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Low Density Level Cholesterol test.
Time frame: 3 months